Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 17, 2010Journal of HepatologyOpen Access

The place of downstaging for hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

CTChristian TosoUniversity of GenevaGMGilles MenthaUniversity of GenevaNKNorman M. KnetemanUniversity of Alberta

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Toso et al. (2010) studied this question.

synapsesocial.com/papers/6a74d2d080fadadbba092a60https://doi.org/10.1016/j.jhep.2009.12.032
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Living Donor Liver Transplant for Malignancy2005 · 32 citations
  2. 2The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria2009 · 47 citations
  3. 3Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database†‡2008 · 332 citations
  4. 4Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma1998 · 100 citations